Top

Published in:

Open Access 01-07-2014 | Others

Clinical practice guideline for dedicated breast PET

Authors: Makoto Hosono, Tsuneo Saga, Kengo Ito, Shinichiro Kumita, Masayuki Sasaki, Michio Senda, Jun Hatazawa, Hiroshi Watanabe, Hiroshi Ito, Shinichi Kanaya, Yuichi Kimura, Hideo Saji, Seishi Jinnouchi, Hiroyoshi Fukukita, Koji Murakami, Seigo Kinuya, Junichi Yamazaki, Mayuki Uchiyama, Koichi Uno, Katsuhiko Kato, Tsuyoshi Kawano, Kazuo Kubota, Takashi Togawa, Norinari Honda, Hirotaka Maruno, Mana Yoshimura, Masami Kawamoto, Yukihiko Ozawa

Published in: Annals of Nuclear Medicine | Issue 6/2014

Excerpt

Dedicated breast positron-emission tomography (dedicated breast PET) is a diagnostic technique using a dedicated breast PET scanner. PET using ¹⁸F-2-deoxy-2-fluoro-d-glucose (hereafter, FDG) is a very useful diagnostic technique in medical examination. In 2002, FDG-PET was employed for health insurance checks on 12 diseases, mainly cancer. Since breast cancer has been covered under insurance from the beginning, the technique has played an important role, mainly in staging and recurrence screening [1]. …

Available only for authorised users

FDG-PET, PET/CT Diagnostic Guideline 2012 (Japanese Society of Nuclear Medicine). Kaku Igaku (Jpn. J. Nucl. Med.) 2012;49(4):39–40.

Ichizawa N, et al. Long-term results of T1a, T1b and T1c Invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification. Jpn J Clin Oncol. 2002;32(3):108–9.PubMedCrossRef

Schilling K, et al. The role of positron emission mammography in breast cancer imaging and management. Appl Radiol. 2008;37(4):26–36.

Berg WA, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J. 2006;12(4):309–23.PubMedCrossRef

Berg WA, et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology. 2011;258(1):59–72.PubMedCentralPubMedCrossRef

Schilling K, et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2011;38(1):23–36.PubMedCentralPubMedCrossRef

Furuta M, et al. Basic evaluation of a C-shaped breast PET scanner. IEEE NSS&MIC 2009 Conference Record 2548–2552.

Iima M, et al. Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation. J Nucl Med. 2012;53(10):1534–42.PubMedCrossRef

Guideline for performing PET scans using FDG manufactured in the hospital (Vol. 2) (Japanese Society of Nuclear Medicine) Kaku Igaku (Jpn. J. Nucl. Med.) 2005;42(4):1–22.

10.

Guideline for imaging techniques in FDG-PET scans (Japanese Society of Nuclear Medicine) The Japanese Journal of Nuclear Medicine Technology 2007;27:425–456.

11.

Narayanan D, et al. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility. AJR Am J Roentgenol. 2011;196(4):971–81.PubMedCentralPubMedCrossRef

12.

ICRP Publication 106. Ann ICRP 2008;38.

13.

Wahl RL, et al. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol. 1993;11(11):2101–11.PubMed

14.

Smith IC, et al. Positron emission tomography using [(18)F]-fluorodeoxy-d-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol. 2000;18(8):1676–88.PubMed

15.

Rousseau C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2006;24(34):3566–72.CrossRef

16.

ACR Practice Guideline for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast. Breast Imaging and Intervention. 10 http://www.acr.org/Quality-Safety/Standards-Guidelines/Practice-Guidelines-by-Modality/media/ACR/Documents/PGTS/guidelines/MRI_Breast/pdf. Resolution 25. 2008.

17.

Mann RM, et al. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18:1307–18.PubMedCentralPubMedCrossRef

18.

Sugano K, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci. 2008;99:1967–76.PubMedCrossRef

19.

Saslow E, et al. American Cancer Society Guidelines for breast screening with MRI as an adjunct to mammography. Cancer J Clin. 2007;57:75–89.CrossRef

20.

Wang CL, et al. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG. AJR Am J Roentgenol. 2011;197(2):247–55.CrossRef

21.

Guideline for breast MRI screening in breast cancer high-risk groups, ver.1.0 Japan Association of Breast Cancer Screening, MRI Screening Committee).

22.

FDG-PET, PET/CT practice guideline 2012 (Japanese Society of Nuclear Medicine), Kaku Igaku (Jpn. J. Nucl. Med.) 2012; 49(4):391–401.

Title: Clinical practice guideline for dedicated breast PET
Authors: Makoto Hosono
Tsuneo Saga
Kengo Ito
Shinichiro Kumita
Masayuki Sasaki
Michio Senda
Jun Hatazawa
Hiroshi Watanabe
Hiroshi Ito
Shinichi Kanaya
Yuichi Kimura
Hideo Saji
Seishi Jinnouchi
Hiroyoshi Fukukita
Koji Murakami
Seigo Kinuya
Junichi Yamazaki
Mayuki Uchiyama
Koichi Uno
Katsuhiko Kato
Tsuyoshi Kawano
Kazuo Kubota
Takashi Togawa
Norinari Honda
Hirotaka Maruno
Mana Yoshimura
Masami Kawamoto
Yukihiko Ozawa
Publication date: 01-07-2014
Publisher: Springer Japan
Published in: Annals of Nuclear Medicine / Issue 6/2014
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-014-0857-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical practice guideline for dedicated breast PET

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2014

Evaluation of the bubble point test of a 0.22-μm membrane filter used for the sterilizing filtration of PET radiopharmaceuticals

Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study

Altered biodistribution of FDG in patients with type-2 diabetes mellitus

Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumors

Effect of surrounding materials on iterative reconstruction-based line-source response function, and annihilations outside the source assessed by a small animal PET scanner

Optimisation of reconstruction—reprojection-based motion correction for cardiac SPECT